Sam Chun Dang Stock Shares Owned By Insiders

Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Based on the latest financial disclosure, 38.64% of Sam Chun Dang are shares owned by insiders. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares owned by insiders for all Republic of Korea stocks is notably lower than that of the firm.

The Macroaxis Fundamental Analysis modules help investors analyze Sam Chun Dang's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sam Chun using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sam Chun Dang based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Sam Chun financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam Chun security.